Early viral reactivation despite excellent immune reconstitution following haploidentical Bone marrow transplant with post-transplant cytoxan for sickle cell disease.

Dilan A PatelNathalie DhedinHeidi ChenLeena KarnikKatie GatwoodKatie CulosSanjay MohanBrian G EngelhardtCarrie KitkoJim ConnellyGowri SatyanarayanaMadan JagasiaJosu De La FuenteAdetola Kassim

Published in: Transplant infectious disease : an official journal of the Transplantation Society (2019)

Further prospective studies are needed to better characterize immune reconstitution and the immunologic basis for increased viral reactivation following haplo-BMT with post-transplant cyclophosphamide for SCD.

Keyphrases

sickle cell disease
bone marrow
sars cov
mesenchymal stem cells
stem cell transplantation
low dose
high dose
peripheral blood
case control